ReviewFrontiers in immunology2026

Licensed and investigational TLR4 agonists as vaccine adjuvants: structural basis, clinical progress, and future directions.

Jiasheng Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.